|
|
Middle area:
Investor Relations Awards
The Investor Relations awards received these last three years reflect the considerable efforts done by management and the Investor Relations team to actively engage with the financial community. “We thank investors and analysts for their votes”, declared Christopher A. Viehbacher, Sanofi CEO. “Our awards recognize the high-quality dialogue between the company and the financial community and underscore Sanofi’s commitment to excellence in Investor Relations”.
Awards 2012
EXTEL Survey 2012
- 1st pan-European quoted company across all sectors
- 1st company in the European pharmaceutical sector
- 1st company among CAC 40
On June 12, 2012, Sanofi was granted the award for “Leading Pan-European Quoted Company for Investor Relations” in the EXTEL survey 2012. For the third year in a row, Sanofi’s Investor Relations was ranked first in France as well as in the European pharmaceutical sector.
AGEFI Awards - “Grands Prix de l’AGEFI de l’Analyse Financière” - 2012
- Best French company for Investor Relations
Sanofi was granted, on June 28, 2012, “Best French company for Investor Relations” in the survey lead by AGEFI. - “Palmarès des Grands prix de l'analyse financière”. AGEFI Hebdo; 28 juin-4 juillet 2012; N°331; p. 30-31 (in French).
- “Les lauréats 2012 des Grands prix de l'analyse financière”. AGEFI Hebdo; 5-11 juillet 2012; N°332; p. 52-53 (in French).
FT Bowen Craggs Index 2012
- 2nd best Investor Relations website
In April 2012, and for the second year in a row, Sanofi’s Investor Relations section of its website ranked second in FT Bowen Craggs Index. The Index covers 81 of the world’s giant corporations.
Awards 2011
EXTEL Survey 2011
- 1st company in the European pharmaceutical sector
- 1st company among CAC 40
- 2nd pan-European quoted company across all sectors
The results of the pan-European EXTEL 2011 study once again recognized the high-quality dialogue between the company and the financial community. For the second year in a row, Sanofi’s Investor Relations was ranked first in France as well as in the European pharmaceutical sector.
AGEFI Awards - “Grands Prix de l’AGEFI de l’Analyse Financière” - 2011
- Best Investor Relations for a French issuer
IR Magazine Europe Awards 2011
- Best Investor Relations by a French company
IR Awards from World Finance 2011
- Best Investor Relations website in France
On July 6, 2011, in the more specific field of online financial communications, the IR Awards 2011 organized by the financial magazine World Finance announced Sanofi as the winner of the Best IR website in France.
IR Forum 2011
- Best Investor Relations across all categories
On November 24, 2011, the 4th edition of the French Investor Relations Forum awarded Sébastien Martel, Vice-President, Investor Relations, the prize for “Best Investor Relations in France across all categories”.
FT Bowen Craggs Index 2011
- 2nd best Investor Relations website
In May 2011, the study of the research and consultancy group Bowen Craggs & Co ranked Sanofi’s IR website ahead of all European pharmaceutical companies and any other CAC 40 companies. It awarded the prize of 2nd best website for his IR pages among the 100 biggest companies in the world.
Awards 2010
EXTEL Survey 2010
- 1st Investor Relations among French listed companies (CAC40)
- 1st Investor Relations among European Pharmaceutical companies
For the first time, Sanofi entered the Top 10 European ranking at the fifth place (all sectors taken together). Sanofi was the one and only pharmaceutical company present in the Top 25 and the first of only 3 companies listed on the French Stock exchange.
IR Forum 2010
- Best Investor Relations by a CEO
Sanofi was recognized by the IR Forum for the first year. In the 2010 edition, Christopher A. Viehbacher received the prize for “Best Investor Relations by a CEO” in France.
Awards 2009
EXTEL Survey 2009For the first time in 2009, Sanofi entered the Top 50 European ranking for all sectors in 31st position.
|
Right area:
Further information
Event
Publications
SEC Filings
|
